Emergent wins FDA all-clear to restart J&J COVID-19 vaccine production in Baltimore
Some three months after federal officials called for a manufacturing pause, Emergent BioSolutions has righted the ship at its beleaguered Bayview facility. Emergent won the FDA’s blessing to restart production of Johnson & Johnson’s COVID-19 vaccine at its Baltimore, Maryland, plant, the company said Thursday. The move follows “extensive” FDA reviews, plus “close coordination” with… Read More »